Shikdar S, Ying Y, Khawandanah M. A Case of Therapy-Related Acute Lymphoblastic Leukemia Following the treatment of Acute Myeloid Leukemia.
Leuk Res Rep 2022;
17:100297. [PMID:
35284228 PMCID:
PMC8904593 DOI:
10.1016/j.lrr.2022.100297]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2021] [Revised: 02/15/2022] [Accepted: 02/28/2022] [Indexed: 11/26/2022] Open
Abstract
Therapy-related acute lymphoblastic leukemia represents a distinct entity associated with inferior survival compared with de novo acute lymphoblastic leukemia. It consists of a subset of patients who have had exposure to chemotherapy or radiation for a previous malignancy. Here, we describe a case of acute myeloid leukemia who later developed precursor B cell acute lymphoblastic leukemia and discuss the current relevant literature. Our case highlights the importance of classifying therapy-related acute lymphoblastic leukemia as a separate as entity based on its biologic and clinical features.
Collapse